Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Immunologist Meeting 2017

About Conference

Immunologist Meeting 2017 is to gathering people in academia and society interested in immunology to share the latest trends and important issues relevant to our field/subject area. Immunologist Meeting 2017 brings together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. The Immunology Conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology. Immunologist Meeting 2017 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. The conference will include invited speakers, oral presentations, poster session and the young scientist award. Conference Series organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Why to attend??

With members from around the world focused on learning about Immunology  and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology  are hallmarks of this conference.
 

Target Audience

Immunology Students, Scientists
Immunology Researchers
Immunology  Faculty
Medical Colleges
Immunology  Associations and Societies
Business Entrepreneurs
Training Institutes
Manufacturing Medical Devices Companies

Scientific Sessions

Immunology:

The Immunology conferences deals with the major branches like Classical immunology, Clinical immunology, Osteoimmunology, Mucosal immunology, Tissue-based immunology. It will broadly classify the cells of immune system, autoimmune diseases, antigen-antibody reactions, T cell development, B cell development, cytokines etc. Immunology has applications in numerous disciplines of medicine, particularly in the fields of organ transplantation, oncology, virology, bacteriology, parasitology, psychiatry, and dermatology. Immunologists employed by universities work in virtually every life science department or division conducting research to increase our understanding of the immune system. 

Related: Immunology Conferences Immunologists Meetings Conference Series LLC

2nd International Conference on Antibodies and Therapeutics,  July 11-12, 2016 Philadelphia, Pennsylvania, USA; 5th European Immunology Conferences, July 21-23, 2016 Berlin, Germany; 7th International Conference on Allergy, Asthma and Clinical Immunology, September 14-15, 2016 Amsterdam, Netherlands; 2nd international conference on innate immunity, July 21-22, 2016, Germany; International Conference on Autoimmunity, October 13-14, 2016 Manchester, UK; Immunology 2016, American Association of Immunologists, Annual Meeting May 13-17, Los Angeles, USA;USA Immunology Conferences; International Conference on Mucosal Immunology, July 28-29, 2016, Australia; International Congress of Immunology

Immunooncology:

Immuno-oncology research have provided solid evidence that tumours are recognised by the immune system and their development can be stopped or controlled long term through a process known as immunosurveillance. Immuno-oncology therapies activate our immune system, making it able to recognize cancer cells and destroy them. Side-effects associated with immuno-oncology therapies are manageable as compared to many other cancer therapies. Immuno-oncology therapies are expected to become an important part of cancer therapy in years to come – along with surgery, radiotherapy, chemotherapy and antibody treatment against tumour-expressed targets (monoclonal antibodies)

Immunology Conferences Immunologists Meetings Conference Series LLC

International Conference on Cancer Immunology & Immunotherapy, July 28-30, 2016, Australia; 2nd International Congress on Neuroimmunology & Therapeutics, December01-03, 2016, USA; International Conference on Tumor Immunology & Immunotherapy, July 28-30, 2016, Australia; 5th  European Immunology Conference, July 21-23, 2016, Germany; Autoimmunity Conferences October 13-14, 2016 Manchester, UK; International Conference on Mucosal Immunology & Vaccine development July 28-29, 2016, Australia; Cancer Diagnostics Conference & Expo, June 13-15, 2016, Italy; 2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany; Japanese Society For Immunology 44th Annual Meeting, November 18-20, 2015 Sapporo, Japan; Society for Immunotherapy of Cancer, November 09-13, 2016, National Harbour, MD; Australasian Society for Immunology, August 21-26, 2016, Melbourne, Australia; British Society for Immunology Congress, December 6 - 9, 2016, Liverpool, UK; 5th Annual Tumor Immunology Research and Emerging Therapies Conference October 2-3, 2015, Marseille, France; The European Academy of Tumor Immunology, November 09-13, 2016, National Harbour, MD.

Immunodiagnostics:

Immunologists are responsible for diagnosing and treating human patients with immunological disorders. They conduct research to develop new diagnostic techniques or therapies, or else based in clinics discussing patient treatment strategies. Immunodiagnostics is a diagnostic methodology that uses an antigen-antibody reaction as their primary means of detection. Well known applications include pregnancy tests, ELISA, immunoblotting, and immunohistochemical staining of microscope slides.     

Immunological research has helped scientists understand the potential causes of many immunological diseases, and enabled them to develop treatments and cures.

Immunology Conferences Immunologists Meetings Conference Series LLC

International Conference on Tumor Immunology & Immunotherapy, July 28-30, 2016, Australia; 5th European Immunology Conference, July 21-23, 2016, Germany; International Conference on Cancer Immunology & Immunotherapy, July 28-30, 2016, Australia; International Conference on Allergy, March 29-30, 2016, Spain; 2nd International Congress on Neuroimmunology & Therapeutics, March 31-Apr 2, 2016, USA; Autoimmunity Conferences October 13-14, 2016 Manchester, UK; International Conference on Mucosal Immunology & Vaccine development July 28-29, 2016, Australia; Cancer Diagnostics Conference & Expo, June 13-15, 2016, Italy; 2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany;Australasian Society for Immunology, August 21-26, 2016, Melbourne, Australia; British Society for Immunology Congress, December 6 - 9, 2016, Liverpool, UK;  5th Annual Tumor Immunology Research and Emerging Therapies Conference October 2-3, 2015, Marseille, France; The European Academy of Tumor Immunology, November 09-13, 2016, National Harbour, MD; Japanese Society For Immunology 44th Annual Meeting, November 18-20, 2015 Sapporo, Japan; Society for Immunotherapy of Cancer, November 09-13, 2016, National Harbour, MD; Annual Immunology events, July 21-23, 2016, Germany.

Immunogenetics:

Immunogenetics is the branch of medical research that explores the relationship between the immune system and genetics. It includes the study of normal immunological pathways and the identification of genetic variations that result in immune defects, which may result in the identification of new therapeutic targets for immune diseases. It focuses on the genetic research areas of autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, Crohn’s disease, diabetes mellitus type 1, systemic lupus erythematous, etc.

Immunology Conferences Immunologists Meetings Conference Series LLC

International Conference on Immunogenetics December 01-02, 2016 San Antonia, USA; International Conference on Tumor Immunology & Immunotherapy, July 28-30, 2016, Australia; 5th European Immunology Conference, July 21-23, 2016, Germany; International Conference on Allergy, March 29-30, 2016, Spain; Autoimmunity Conferences October 13-14, 2016 Manchester, UK; International Conference on Mucosal Immunology & Vaccine development July 28-29, 2016, Australia; Cancer Diagnostics Conference & Expo, June 13-15, 2016, Italy; 2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany; Australasian Society for Immunology, August 21-26, 2016, Melbourne, Australia; British Society for Immunology Congress, December 6 - 9, 2016, Liverpool, UK;  5th Annual Tumor Immunology Research and Emerging Therapies Conference October 2-3, 2015, Marseille, France; The European Academy of Tumor Immunology, November 09-13, 2016, National Harbour, MD; Japanese Society For Immunology 44th Annual Meeting, November 18-20, 2015 Sapporo, Japan; Society for Immunotherapy of Cancer, November 09-13, 2016, National Harbour, MD; Annual Immunology events, July 21-23, 2016, Germany.

Market Analysis

Immunology deals with different branches like Tumor Immunology, Cancer Immunology, Clinical Immunology , , Immunotherapy etc. Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. Although they are often disparate in terms of their symptoms and key patient demographics, they are pathophysiologically linked, being characterized by dysregulation of immune pathways and an inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a highly genericized class of systemic small-molecule-based agents, are used in the first-line treatment of these diseases. These are supplemented in many cases by shorter-term glucocorticoid therapy, another class of highly genericized systemic agents

Scope & Importance

Global Immunology Market to 2022 has  Large pipeline and competitive market to drive long-term market growth. There is a very large pharmaceutical pipeline for immunology, consisting of 1,838 products in active development. However, the commercial performance of the products in the late-stage pipeline is expected to be moderate.

Although the patents for many of these mAbs either have already expired or are due to expire during the forecast period, the market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%.Despite the imminent patent expiry of many therapies, the global immunology treatment market is set to expand, from $61.5 billion in 2015 to reach $74.2 billion in 2022, says business intelligence provider GBI Research. The under developed and developing countries such as Asia, Africa and some more are the biggest target regions for the earlier mentioned statistics. Around 82% of the total cases are registered from the children in Asia and Africa. Latest market research report published on Infectious Immunology Reagents Instruments and provides detailed industry analysis and in-depth market data for the period from 2012 to 2024.

Global Data estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The main drivers of this growth will come from immune checkpoint inhibitors, which will have sales of approximately $10 billion in 2019, rising to $24 billion by 2024. The highest-selling IO drugs by 2024 will be Opdivo and Keytruda, both PD-1 inhibitors, with sales of approximately $10 billion and $7 billion, respectively. This is because these two drugs will be first-to-market in many indications, leapfrogging competition such as Roches atezolizumab and AstraZenecas durvalumab.

Prominent Top Competitors:

Apart from the market segmentation, Key Market Insights on the Past, Future & Present of the Immunology Market, this report includes an in-depth analysis and study on the Key Players at a Global Scale. Abbive, Johnson & Johnson, Amgen, Roche, UCB,Eli Lilly, Sanofi, Novartis, PathoGenesis, Intrinsic.Here is the graph presnting the companies key players in the market, all of which are among the top 20 pharmaceutical companies, are expected to maintain their market lead throughout the forecast period 2015-2022.  

 

Continental Distribution of Pharma Companies:

Contribution of the Immunological Research world wide 

 
 
Different Funding Sources For Immunology Research areas 
 
 
 

 

Past Conference Report

Immunology Summit-2015

With the overwhelming success of the previous conferences, OMICS International hosted the 4th International Conference and Exhibition on Immunology during October 28-30, 2015 at Crowne Plaza Houston River Oaks with the theme “From Basic Immune Understanding to latest Immunology Breakthroughs”.  Benevolent response and active participation was received from the renowned experts and Editorial Board Members of OMICS International Journals as well as from the Immunologists, scientists, researchers, students and leaders in Immunology, who made this event successful.                                             
The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Infectious Diseases, Emerging and Reemerging diseases: Confronting Future Outbreaks
  • Immunology and Diabetes
  • Immune Tolerence
  • Viral Immunology: Emerging and Re-emerging Diseases
  • Immunoinformatics and Systems Immunology
  • Reproductive Immunology
  • Rheumatology/Orthopedics
  • Cytokines and Current Research
  • Vaccines and Immunotherapy
  • Mucosal immunology
  • Inflammation and Therapies
  • Allergy and Asthma
  • Immunologic Techniques, Microbial Control and Therapeutics
  • Transplantation Immunology
  • Cellular Immunology and Latest Innovations
  • Antibodies : Engineering and Therapeutics
  • Immunodeficiency
  • Innate Immunity: An Emerging Science
  • Bacterial Pathogenesis and Immunology
  • Immunopathology
  • Nutritional Immunology: A Multi-Dimensional Approach
  • Fungal Immunology
  • Autoimmune Diseases
  • Neuroimmunology
  • Pediatric Immunology
  • Immunotoxicology
  • Molecular Immunology
  • Immuno Cytochemistry, Immunohistochemistry and Immunobiology
  • Parasite Immunology
  • Immunotherapy & Cancer Immunotherapy: From Basic Biology to Translational Research
  • Veterinary Immunology and Immunopathology
  • Immunogenecity and Immunotoxicology
  • Food & Agricultural Immunology
  • Clinical Immunology: Current & Future Research
  • Review and debate on latest discoveries in Immunology
  • Lung Immunology
  • Antibiotics and Current Research
  • Occular Immunology

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Charles J. Malemud, Case Western Reserve University School of Medicine, USA
Michael G. Hanna, Vaccinogen, Inc., USA
Yongqun Oliver He, University of Michigan Medical School, USA
Johnny Huard, University of Texas Health Science Center at Houston, USA
Robert H Schiestl, University of California, USA
Madeleine Duvic, The University of Texas MD Anderson Cancer Center, USA
Ahmed G Hegazi, National Research Center, Egypt

We would like to acknowledge our sincere thanks and support to our honorable organizing committee members

Moderator  and Scientific Committee Chief 
Charles J. Malemud
Rheumatology, Professor of Medicine
Case Western Reserve University, USA 
Editor in Chief, Journal of Clinical & Cellular Immunology (JCCI) ISSN: 2155-9899

Conference President
Yongqun Oliver He
University of Michigan Medical School, USA
Editor in Chief, Immunome Research (IMR), ISSN: 1745-7580

Conference Sessions Chairs at Immunology Summit-2015

Charles J. Malemud
Case Western Reserve University School of Medicine, USA

Yongqun Oliver He
University of Michigan Medical School, USA

Michael G Hanna
Vaccinogen, Inc., USA

Kamalakannan Rajasekaran
Blood Research Institute, USA

Best Poster Award winners at Immunology Summit-2015

Title: Antibodies against epitopes on HN domain of botulinum neurotoxin- A protect against toxin poisoning
B Vijayalakshmi Ayyar, Baylor College of Medicine, USA

Title: Novel peptide inhibitors of human tumor necrosis factor-α: Molecular modelling and in-vitro assays
Debasis Sahu, National Institute of Immunology, India

OMICS International offers its heartfelt appreciation to Societies and Organizations includes Vaccinogen, Auto Immunity Network, and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with OMICS International in supporting and making the conference a never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Immunology Summit-2015, OMICS International is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza,"5th International Conference and Exhibition on Immunology" to be held during October 24-26, 2016 at DoubleTree by Hilton Hotel Chicago North Shore Conference Center, Chicago, USA.

 For More details: http://immunology.conferenceseries.com/


Past Reports  Proceedings  Gallery  

Immunology Summit-2014

With the trail of success of the previous conference, OMICS Group hosted the 3rdInternational Conference and Exhibition on Clinical & Cellular Immunology duringSeptember 29-October 01, 2014 at DoubleTree by Hilton Baltimore-BWI Airport, Baltimore, USA with the theme From Basic Immune Understanding to Clinical Breakthroughs”.  Benevolent response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the Immunologists, scientists, researchers, students and leaders from the fields of Clinical and Cellular Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following 17 thought provoking and cerebrating scientific tracks:

Clinical Immunology
Cellular Immunology
Inflammatory/Autoimmune Diseases
Cancer and Tumor Immunobiology
Vaccines
Immunotherapy
Infectious Diseases and Immune System
Auto Immunity
Autoimmunity and Therapathies
Allergy and Therapathies
Antigen Processing
T-Cells and B-Cells
Neuro Immunology
Reproductive Immunology
Costimmulatory Pathways
Diagnostic Immunology
Technological Innovations in Immunology
Immunoinformatics and Systems Immunology
Rheumatology
Nutritional Immunology


The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Charles J. Malemud, Case Western Reserve University, USA

Dr. Michael G. Hanna, Vaccinogen, Inc., USA

Dr. Howard A Young, National Cancer Institute-Frederick, USA
Dr. Yongqun Oliver He, University of Michigan Medical School, USA
Dr. Warren J Leonard, National Institutes of Health, USA
Dr. Yehuda Shoenfeld, Tel-Aviv University, Israel


OMICS Group International offers its heartfelt appreciation to Societies and Organizations such as    Vaccinogen, International Immunomics Society, AutoImmunity Network, BMJD, Labroots, Medical College of Wisconsin and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with OMICS group in supporting and making the conference a never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Immunology Summit-2014, OMICS Group is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza,"4th International Conference and Exhibition on Immunology" to be held during September 28-30, 2015 at Houston, USA.

For More details: http://immunology.conferenceseries.com/

 


Past Reports  Proceedings  Gallery  

Immunology Summit-2013

With the trail of success of the previous conference,  OMICS Group  hosted the2nd International Conference and Exhibition on Clinical & Cellular Immunology  duringOctober 15-17, 2013 at Hampton Inn Tropicana, Las Vegas, USA with the themeDisseminating the New Trends in Immunology”.  Benevolent response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the scientists, engineers, researchers, students and leaders from the fields of Clinical and Cellular Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following 17 thought provoking and cerebrating scientific tracks:

  • Molecular and Cellular Immunology
  • Innate and Adaptive Immune System
  • Inflammatory/Autoimmune Diseases
  • Immunomodulation and Immunotherapy
  • Immunology and Epidemiology of Major Diseases
  • Cancer Immunology
  • Vaccines in Immunology: New Insights and Development
  • Emerging Issues in Immunology and Reproductive Immunology
  • Biomarkers and Techniques in Immunology
  • Transplantation: Immune System
  • Immunology: Ethical Dimension
  • Neuroimmunology
  • Cytokine Biology
  • Allergy and Immunology
  • Immunodeficiency: Current research
  • Antibiotics and Innovation
  • Rheumatology

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Michael A. Tainsky, Wayne State University School of Medicine, USA

Dr. Charles J. Malemud, Case Western Reserve University, USA

Dr. Michael G. Hanna, Vaccinogen, Inc., USA

Dr. Jianfei Yang, Tempero Pharmaceuticals, a GSK Company, USA

Dr. Sergei A. Grando University of California, USA.


OMICS Group International offers its heartfelt appreciation to organizations such as   VaccinogenBentham Science GroupMedTubeFEMS (Federation of European Microbiological Societies), Labroots and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with OMICS group in supporting and making the conference a never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Immunology Summit-2013, OMICS Group is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza,  "3rd International Conference and Exhibition on Clinical & Cellular Immunology" to be held during September 29-October 01, 2014 at Baltimore, USA.

 For More details: http://immunologysummit2014.conferenceseries.net/#


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 03-05, 2017

For Sponsors & Exhibitors

Sponsorship Opportunities

Speaker Opportunity

Supported By

Journal of Clinical & Cellular Immunology Immunome Research Journal of Allergy & Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by